KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Amortization of Deferred Charges (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Amortization of Deferred Charges for 17 consecutive years, with $22.0 million as the latest value for Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 57.14% to $22.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94.0 million through Dec 2025, up 70.91% year-over-year, with the annual reading at $94.0 million for FY2025, 70.91% up from the prior year.
  • Amortization of Deferred Charges hit $22.0 million in Q4 2025 for Bausch Health Companies, up from $16.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $50.0 million in Q2 2022 to a low of $11.0 million in Q1 2023.
  • Historically, Amortization of Deferred Charges has averaged $18.4 million across 5 years, with a median of $14.0 million in 2022.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 316.67% in 2022 and later tumbled 76.0% in 2023.
  • Year by year, Amortization of Deferred Charges stood at $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then rose by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then skyrocketed by 57.14% to $22.0 million in 2025.
  • Business Quant data shows Amortization of Deferred Charges for BHC at $22.0 million in Q4 2025, $16.0 million in Q3 2025, and $41.0 million in Q2 2025.